Trademark: 97123429
Status Date
Tuesday, May 23, 2023
Registration Number
7058751
Registration Date
Tuesday, May 23, 2023
Filing Date
Friday, November 12, 2021
Published for Opposition
Tuesday, March 7, 2023
41 Providing of on-line training and continuing education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; Educational services, namely, providing continuing professional education courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from depression and anxiety related to Pulmonary Fibrosis and for medical personnel specialized on the treatment of depression and anxiety
9 Downloadable computer software with medical information and content for facilitating the provision of medical advice in the field of depression and anxiety related to Pulmonary Fibrosis; downloadable computer software programs for the administration of scientific content in the nature of analysis of medical data; downloadable computer programs, in particular interactive downloadable medical software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; downloadable computer software program which is designed to assist patients in reducing and coping with the symptoms of depression and anxiety related to Pulmonary Fibrosis as well as in improving their wellbeing and social occupational functioning and to support health care professionals involved in the treatment of patients with depression and anxiety related to Pulmonary Fibrosis by facilitating the provision of medical advice; downloadable computer application software for websites, mobile telephones and mobile devices, namely, software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; Downloadable printable educational materials featuring therapeutic medical and counseling content, in the nature of information, forms, instructions, charts, studies, data and related coaching and advice in the field of depression and anxiety related to Pulmonary Fibrosis, treatment of depression and anxiety related to Pulmonary Fibrosis, and related health and wellness; Downloadable electronic publications, namely, newsletters and articles for use by medical professionals and patients in the field of depression and anxiety related to Pulmonary Fibrosis
44 Therapeutic services, namely, medical counselling, psychological counselling, medical advice and medical information provided to patients with, and care givers treating, depression and anxiety related to Pulmonary Fibrosis; Providing medical information, namely, computer-based interactive medical support services, in the nature of providing online medical advice for assisting with treatment of patients suffering from depression and anxiety related to Pulmonary Fibrosis and their families; Medical treatment of depression and anxiety by medical personnel
42 Providing a website featuring digital therapeutic technology that enables users to access resources for treating depression and anxiety related to Pulmonary Fibrosis; providing an online digital therapeutic platform in the nature of providing on-line non-downloadable software for providing behavioral health services, namely, coaching, counseling, advice in the field of depression and anxiety related to Pulmonary Fibrosis; conducting medical and scientific and technological research in the field of depression and anxiety related to Pulmonary Fibrosis; Scientific and technological services, namely, conducting technological research and design of digital therapeutics for computer-based interactive and online psychological intervention and counseling in the field of depression and anxiety related to Pulmonary Fibrosis; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of depression and anxiety related to Pulmonary Fibrosis and the treatment of depression and anxiety related to Pulmonary Fibrosis
May 23, 2023
Notice Of Registration Confirmation Emailed
May 23, 2023
Registered-Principal Register
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2023
Published For Opposition
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 1, 2023
Approved For Pub - Principal Register
Feb 1, 2023
Examiner's Amendment Entered
Feb 1, 2023
Notification Of Examiners Amendment E-Mailed
Feb 1, 2023
Examiners Amendment E-Mailed
Feb 1, 2023
Examiners Amendment -Written
Jan 19, 2023
Notification Of Non-Final Action E-Mailed
Jan 19, 2023
Non-Final Action E-Mailed
Jan 19, 2023
Non-Final Action Written
Jan 9, 2023
Teas/Email Correspondence Entered
Jan 9, 2023
Correspondence Received In Law Office
Jan 6, 2023
Assigned To Lie
Nov 9, 2022
Teas Response To Office Action Received
Sep 2, 2022
Notification Of Non-Final Action E-Mailed
Sep 2, 2022
Non-Final Action E-Mailed
Sep 2, 2022
Non-Final Action Written
Aug 23, 2022
Assigned To Examiner
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 16, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
